Physician profile
Adam Benjamin Weiner
NPI 1104288356
$1,966.55
in general payments reported to CMS, 2019-2025
14 companies · $506 in 2025
The $506 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $138 · 2022: $212 · 2023: $393 · 2024: $718 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,533 · Education: $83.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.55 |
| Education | $83.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $335.66 | 2024-2025 | |
| Boston Scientific Corporation | $303.06 | 2021-2023 | |
| Astellas Pharma US INC | $259.42 | 2023-2024 | Xtandi, Padcev, Izervay |
| Pfizer INC. | $168.05 | 2023-2025 | |
| Dendreon Pharmaceuticals LLC | $140.72 | 2023 | Provenge |
| Edap Technomed INC | $135.14 | 2025 | |
| Blue Earth Diagnostics | $119.57 | 2024 | |
| Travere Therapeutics, INC. | $115.96 | 2021 | |
| Janssen Scientific Affairs, LLC | $85.66 | 2024 | Erleada |
| Janssen Biotech, INC. | $82.56 | 2024-2025 | Erleada |
| Aroa Biosurgery Incorporated | $77.42 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $77.33 | 2024 | |
| Progenics Pharmaceuticals, INC. | $50.41 | 2024 | |
| Solventum Corporation | $15.59 | 2025 | V.A.C. Granufoam, Abthera, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Weiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.